Kisqali
| Package | Price | Savings |
|---|
| Active Ingredient | Ribociclib |
| Packaging Type | tablet |
| Quantity per Package | 21 |
| Price of Kisqali | From EUR 107,15 per tablet |
| Dosage | 200mg |
| Sale of Kisqali | without prescription |
In our online pharmacy, you can purchase Kisqali without a prescription. We guarantee a seamless purchasing experience by providing access to high-quality medication in an easy and confidential manner.
Yes, like any medication, Kisqali may not work for everyone, as individual responses vary.
No, the contents of your order with Kisqali are strictly confidential. All orders are securely packaged without any external labeling that could reveal the contents, ensuring absolute discretion. We prioritize the privacy of our customers, and no third party will be informed of the details of your order.
Kisqali is a prescription medicine used to treat certain types of breast cancer. It works by blocking proteins that allow cancer cells to multiply, thereby slowing or stopping the growth of the cancer.
Yes, Kisqali (ribociclib) is approved for use in Canada for the treatment of certain types of breast cancer in combination with other medications.
Kisqali (ribociclib) is a selective inhibitor of cyclin-dependent kinases 4 and 6, which play a crucial role in cell cycle progression, thereby inhibiting tumor cell growth and proliferation.
Kisqali typically starts working within a few weeks, but it may take up to three months to see the full effects on slowing or stopping the growth of breast cancer cells.
Kisqali’s effects typically last until the next scheduled dose. Its active ingredient has a half-life of around 37 hours, so it maintains therapeutic levels in the body for an extended period.
Kisqali may cause side effects like nausea, fatigue, diarrhea, and low white blood cell count. It should be used as prescribed and under medical supervision.
Kisqali (ribociclib) typically stays in the body for around 32 hours after the last dose, with most of the drug eliminated within 4 days.
Kisqali (ribociclib) is a prescription medication and may potentially cause a false positive on certain drug tests, so it’s advisable to disclose its use if undergoing drug screening.
Kisqali may interact with:
– Certain antibiotics
– Antifungal medications
– Anti-seizure drugs
– HIV/AIDS medications
Contact our support for more details about potential interactions.
Although moderate alcohol consumption is generally not prohibited when taking Kisqali (Ribociclib), it’s always best to consult your healthcare provider. They can offer personalized advice based on your overall health condition, medication dosage, and potential risks of interactions.
Kisqali (ribociclib) should be taken as follows:
| Dosage | 600 mg (three 200 mg tablets) once daily for 21 consecutive days, followed by 7 days off treatment. |
|---|---|
| Administration | Swallow tablets whole, with or without food. Do not chew, crush or split tablets. |
Kisqali is typically prescribed for extended periods as it helps treat advanced or metastatic breast cancer when used in combination with other medications.
In the rare event of an overdose of Kisqali, it is generally not considered potentially fatal. However, it’s important to seek appropriate medical assistance. If you suspect an overdose, you should:
Remember, prompt action is crucial for effectively managing the situation without unnecessary alarms.
Kisqali (ribociclib) is a cyclin-dependent kinase 4/6 inhibitor used in combination with an aromatase inhibitor for the treatment of advanced or metastatic breast cancer in postmenopausal women. Compared to other medications in the table, such as ibrutinib (for mantle cell lymphoma), flutamide (anti-androgen), and norethindrone acetate (progestin), Kisqali has a distinct mechanism of action and therapeutic indication.
Kisqali is a prescription medication used to treat certain types of breast cancer. Before taking it, women should discuss their medical history, potential side effects, and other treatment options with their healthcare provider.
Kisqali (ribociclib) is contraindicated in patients with severe hepatic impairment and those with hypersensitivity to the active ingredient or any of the excipients. List of contraindications: severe hepatic impairment, hypersensitivity to ribociclib or excipients. Kisqali should be used with caution in patients with pre-existing conditions and potential drug interactions should be considered.
Kisqali (ribociclib) is a medication used to treat certain types of breast cancer. Some of the possible side effects include:
It’s important to discuss all potential side effects with your healthcare provider and report any concerning symptoms promptly.
Kisqali promotes a healthy lifestyle, including a balanced diet and regular exercise, for optimal treatment benefits without serious side effects.
Kisqali’s effectiveness may be influenced by a patient’s mental state, as stress and anxiety can potentially impact treatment response and adherence to prescribed regimens. A positive mindset and proper support systems are beneficial for optimal results with Kisqali.
Always consult your doctor if you experience any unusual symptoms or side effects while taking Kisqali (ribociclib). It’s important to follow your doctor’s instructions and attend regular check-ups for monitoring. Inform your doctor about any other medications you’re taking to avoid potential interactions. Don’t stop or change your dosage without consulting your healthcare provider.
In our pharmacy, Kisqali is available at the most competitive price, ensuring you the best value compared to other suppliers. While other stores may offer quality, our exclusive deals ensure you get premium medication without overpaying. Buy from us and experience the perfect blend of affordability and reliable quality.
Kisqali is available for delivery in the following cities in Canada:
| City | Province | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Montreal | Quebec | 5-9 days |
| Calgary | Alberta | 5-9 days |
| Edmonton | Alberta | 5-9 days |
| Ottawa | Ontario | 5-9 days |
| Winnipeg | Manitoba | 5-9 days |
| Quebec City | Quebec | 5-9 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| St. John’s | Newfoundland and Labrador | 5-9 days |
For additional locations and delivery inquiries, please contact our support team.
